Literature DB >> 12898437

Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.

Philippe Berthelot1, Ina Attree, Patrick Plésiat, Jacqueline Chabert, Sophie de Bentzmann, Bruno Pozzetto, Florence Grattard.   

Abstract

The type III secretion system (TTSS) of Pseudomonas aeruginosa was characterized genetically and phenotypically in 92 epidemiologically unrelated bacteremic strains. Four groups of strains (TTSS types) were defined according to the level of type III protein secretion and kinetics of cytotoxicity. Type 1 strains (n=26) were highly and rapidly cytotoxic and secreted ExoU, type 2 strains (n=48) exhibited slower cytotoxic rates and expressed ExoS but not ExoU, type 3 strains (n=14) were poorly cytotoxic, and type 4 strains (n=4) were not cytotoxic. Type 3 and 4 strains did not have detectable secretion phenotype; however, some type 4 strains were able to reach a level of cytotoxicity similar to that of type 1 and type 2 strains when complemented in trans by a functional exsA gene. A statistically significant association (P<.001) was found between TTSS types and detection of the mutually exclusive exoU and exoS genes. In addition, 24 of 25 serotype O:1, O:10, and O:11 strains contained exoU, whereas 54 of 55 serotype O:3, O:4, O:6, O:12, and O:16 strains contained exoS (P<.001). Our results demonstrate correlations among exoU or exoS genotype, TTSS phenotype, and O serotype in bacteremic P. aeruginosa isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898437     DOI: 10.1086/377000

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  33 in total

1.  Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.

Authors:  Raúl Recio; Mikel Mancheño; Esther Viedma; Jennifer Villa; María Ángeles Orellana; Jaime Lora-Tamayo; Fernando Chaves
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

2.  Presence of the exoU gene of Pseudomonas aeruginosa is correlated with cytotoxicity in MDCK cells but not with colonization in BALB/c mice.

Authors:  Hsi-Hsun Lin; Shiao-ping Huang; Hsiu-Chen Teng; Dar-Der Ji; Yao-Shen Chen; Ya-Lei Chen
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

3.  Genetic characterization indicates that a specific subpopulation of Pseudomonas aeruginosa is associated with keratitis infections.

Authors:  Rosalind M K Stewart; Lutz Wiehlmann; Kevin E Ashelford; Stephanie J Preston; Eliane Frimmersdorf; Barry J Campbell; Timothy J Neal; Neil Hall; Stephen Tuft; Stephen B Kaye; Craig Winstanley
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

4.  Effects of human β-defensin 3 fused with carbohydrate-binding domain on the function of type III secretion system in Pseudomonas aeruginosa PA14.

Authors:  Yunqiang Wu; Yanan Liu; Ke Dong; Qingtian Li
Journal:  Braz J Microbiol       Date:  2020-01-13       Impact factor: 2.476

5.  Environmental reservoirs for exoS+ and exoU+ strains of Pseudomonas aeruginosa.

Authors:  Victoria Rutherford; Kelly Yom; Egon A Ozer; Olivia Pura; Ami Hughes; Katherine R Murphy; Laura Cudzilo; David Mitchell; Alan R Hauser
Journal:  Environ Microbiol Rep       Date:  2018-08       Impact factor: 3.541

6.  Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.

Authors:  Ali A El-Solh; Angela Hattemer; Alan R Hauser; Ahmad Alhajhusain; Hardik Vora
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

7.  Pharmacological activation of Rap1 antagonizes the endothelial barrier disruption induced by exotoxins ExoS and ExoT of Pseudomonas aeruginosa.

Authors:  Stéphanie Bouillot; Ina Attrée; Philippe Huber
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

8.  Type III secretion phenotypes of Pseudomonas aeruginosa strains change during infection of individuals with cystic fibrosis.

Authors:  Manu Jain; Daniel Ramirez; Roopa Seshadri; Joanne F Cullina; Catherine A Powers; Grant S Schulert; Maskit Bar-Meir; Christine L Sullivan; Susanna A McColley; Alan R Hauser
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

9.  The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes.

Authors:  Julien Goure; Alexandrine Pastor; Eric Faudry; Jacqueline Chabert; Andréa Dessen; Ina Attree
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.

Authors:  Katy Jeannot; Sylvie Elsen; Thilo Köhler; Ina Attree; Christian van Delden; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.